Arena Investors »

Phoenix Biotech Acquisition Class A shares owned by Arena Investors

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Arena Investors from 13F filings

Historical chart of Arena Investors investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Arena Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Arena Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $59k 199k 0.30

More positions owned by Arena Investors

Beyond Meat Option Put Option
Beyond Meat Note (Principal)
HashiCorp Equity (HCP)
Invesco QQQ Trust Series 1 Option Put Option
Spdr S&p500 Etf Trust Option Put Option
iShares J.P. Morgan USD Emerging Markets Bond ETF Option Put Option
Prime Number Holding Equity (NCNC)
iShares iBoxx High Yield Corporate Bond ETF Option Put Option
Elicio Therapeutics Equity (ELTX)
Edible Garden Warrant (EDBLW)
Phoenix Biotech Acquisition Equity (CERO)
Yotta Acquisition Corp Rights (YOTAR)
Tenzing Acquisition Corp Warrant (RVPHW)
Kernel Group Holdings Warrant (QQQ)
Oxbridge Acquisition Corp Warrant (JTAIW)

View all positions for Arena Investors

Top funds holding Phoenix Biotech Acquisition Class A

Arch Venture Corp
Arena Investors
Honkamp Krueger Financial Services
Fifth Lane Capital
Geode Capital Management
Jane Street
Two Sigma Investments
CI Private Wealth
Birchview Capital
Hrt Financial
FNY Investment Advisers
Pineridge Advisors
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Phoenix Biotech Acquisition Class A